"I want to share my story and help others like myself living with MPN. MPN Research Foundation has been that source of community support for my family and I as we learn to deal with living with a disease on a daily basis."

News

Help me find

Incyte reports positive results of JAK Inhibitor tested in Essential Thrombocythemia and Polycythemia Vera patients

December 2010

Incyte Corp. is currently working on phase II clinical trials for their JAK Inhibitor INCB18424. These trials are testing safety and efficacy of this drug, meant to relieve constitutional symptoms in ET and PV patients. Results were reported at the American Society of Hematology's annual meeting.

Click here for more information

 

Your donation goes a long way.

Learn more about how you can help support the MPN Research Foundation and the impact your contributions can make.

Donate Now
 
 
 

Subscribe

Want to learn more about the MPN Research Foundation? Sign up for our Newsletter and Research Alerts!

Newsletter Signup

 
 

Connect with Us

MPN Research Foundation wants to hear from you. Connect with us through our social networks or send us an email.

Email Facebook Twitter LinkedIn